Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation elongation factor 1 alpha 1 pseudogene 36 (EEF1A1P36) is a human pseudogene locus annotated as related to the protein-coding gene *EEF1A1* (Eukaryotic translation elongation factor 1 alpha 1), which is central to protein synthesis during the elongation step of mRNA translation[3]. Pseudogenes like EEF1A1P36 generally do not encode functional proteins, often due to disruptive mutations or genomic rearrangement, though some pseudogenes may be transcribed as non-coding RNAs with potential regulatory effects[2][3]. There is no evidence that EEF1A1P36 encodes a protein or plays a direct, characterized biological or therapeutic role, nor is it a characterized target for drugs, disease biomarkers, or related to known safety or therapeutic challenges[2][3]. It is part of a large family of EEF1A1 pseudogenes (over 40 in the human genome), most of which remain unstudied with respect to biological function or disease association[2]. **Note:** - EEF1A1P36 is not a classical drug target such as a receptor, enzyme, transporter, or transcription factor; it is a pseudogene[3]. - There is no documentation of therapeutic intervention, biomarker value, or mechanism of action related to EEF1A1P36 specifically. - The biological functions and disease associations documented for *EEF1A1* do not directly extend to EEF1A1P36, though pseudogenes in this family can sometimes regulate their parental genes, but this is unproven for EEF1A1P36[2][3]. - This entry is considered "incorrect" as a conventional target due to its nature as a pseudogene and lack of direct functional/therapeutic significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 36 (EEF1A1P36).